Is Applied Therapeutics, Inc. (APLT) a Buy, Sell, or Hold?
Applied Therapeutics, Inc.
NASDAQ:APLT
$0.103 USD
$0.0 (0.0%)
- Volume
- 0
- Average Volume
- 15.8M
- Market Capitalization
- $14.86M
- P/E Ratio
- -0.24
- Dividend Yield
- 0.00%
- Price Target
- $2.13
- Year High
- $1.50
- Year Low
- $0.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.96
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
12
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
26
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 6.91M
APLT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
APLT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kanter Stacy J. | director | 2026-02-03 | D-Return | 0.088 | 2026-02-04 |
| Kanter Stacy J. | director | 2026-02-03 | D-Return | 0.395 | 2026-02-04 |
| Kanter Stacy J. | director | 2026-02-03 | U-Tender | 0.088 | 2026-02-04 |
| Kanter Stacy J. | director | 2026-02-03 | D-Return | 1.05 | 2026-02-04 |
| Hooks Corwin Dale | officer: Chief Commercial Officer | 2025-12-19 | A-Award | 0 | 2026-02-03 |
| Hooks Corwin Dale | officer: Chief Commercial Officer | 2026-02-03 | D-Return | 0.088 | 2026-02-03 |
| Hooks Corwin Dale | officer: Chief Commercial Officer | 2026-02-03 | U-Tender | 0 | 2026-02-03 |
| Chinoporos Constantine | officer: See Remarks | 2025-12-19 | A-Award | 0 | 2026-02-03 |
| Chinoporos Constantine | officer: See Remarks | 2026-02-03 | D-Return | 0.088 | 2026-02-03 |
| Chinoporos Constantine | officer: See Remarks | 2026-02-03 | U-Tender | 0 | 2026-02-03 |
| SKYLER JAY S | director | 2026-02-03 | D-Return | 0.088 | 2026-02-03 |
| SKYLER JAY S | director | 2026-02-03 | D-Return | 0.395 | 2026-02-03 |
| SKYLER JAY S | director | 2026-02-03 | D-Return | 1.05 | 2026-02-03 |
| SKYLER JAY S | director | 2026-02-03 | U-Tender | 0.088 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2025-12-19 | A-Award | 0 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2026-02-03 | D-Return | 0.088 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2026-02-03 | U-Tender | 0 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2026-02-03 | D-Return | 4.7 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2026-02-03 | D-Return | 1.02 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2026-02-03 | D-Return | 1.05 | 2026-02-03 |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2025-12-19 | A-Award | 0 | 2026-02-03 |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2026-02-03 | D-Return | 0.088 | 2026-02-03 |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2026-02-03 | D-Return | 1.05 | 2026-02-03 |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2026-02-03 | U-Tender | 0 | 2026-02-03 |
| Lerner Teena | director | 2026-02-03 | D-Return | 0.088 | 2026-02-03 |
| Lerner Teena | director | 2026-02-03 | D-Return | 1.05 | 2026-02-03 |
| Lerner Teena | director | 2026-02-03 | D-Return | 0.395 | 2026-02-03 |
| Lerner Teena | director | 2026-02-03 | U-Tender | 0.088 | 2026-02-03 |
| Lerner Teena | director | 2026-02-03 | D-Return | 4.7 | 2026-02-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2026-01-01 | A-Award | 0 | 2026-01-02 |
| Kanter Stacy J. | director | 2025-12-16 | S-Sale | 0.112 | 2025-12-18 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2025-10-01 | A-Award | 0 | 2025-10-01 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2025-07-01 | A-Award | 0 | 2025-07-03 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2025-06-09 | A-Award | 0 | 2025-07-03 |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2025-06-15 | A-Award | 0 | 2025-06-17 |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2025-06-15 | 0 | 2025-06-17 | |
| Bailey Evan Prescott | officer: Chief Medical Officer | 2025-06-15 | 1.5 | 2025-06-17 | |
| Lerner Teena | director | 2025-06-09 | A-Award | 0.395 | 2025-06-11 |
| Kanter Stacy J. | director | 2025-06-09 | A-Award | 0.395 | 2025-06-11 |
| SKYLER JAY S | director | 2025-06-09 | A-Award | 0.395 | 2025-06-11 |
| Hooks Corwin Dale | officer: Chief Commercial Officer | 2025-03-24 | A-Award | 0 | 2025-03-26 |
| Funtleyder Leslie D. | director, officer: See Remarks | 2025-03-24 | A-Award | 0 | 2025-03-26 |
| Chinoporos Constantine | officer: See Remarks | 2025-03-24 | A-Award | 0 | 2025-03-26 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2025-03-04 | S-Sale | 0.44 | 2025-03-06 |
| Funtleyder Leslie D. | director, officer: See Remarks | 2025-03-04 | S-Sale | 0.44 | 2025-03-06 |
| Chinoporos Constantine | officer: See Remarks | 2025-03-04 | S-Sale | 0.44 | 2025-03-06 |
| Funtleyder Leslie D. | director, officer: See Remarks | 2025-02-06 | S-Sale | 0.61 | 2025-02-07 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2025-02-06 | S-Sale | 0.61 | 2025-02-07 |
| Chinoporos Constantine | officer: See Remarks | 2025-02-06 | S-Sale | 0.61 | 2025-02-07 |
| JOHNSON JOHN | director, officer: Executive Chairman | 2024-12-19 | A-Award | 1.02 | 2024-12-20 |
| JOHNSON JOHN | director, officer: Executive Chairman | 2024-12-19 | A-Award | 0 | 2024-12-20 |
| Funtleyder Leslie D. | director, officer: See Remarks | 2024-12-19 | A-Award | 0 | 2024-12-20 |
| Funtleyder Leslie D. | director, officer: See Remarks | 2024-12-19 | A-Award | 1.02 | 2024-12-20 |
| JOHNSON JOHN | 2024-12-19 | 0 | 2024-12-20 | ||
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2024-08-22 | S-Sale | 5.83 | 2024-08-23 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2024-08-22 | S-Sale | 5.83 | 2024-08-23 |
| Shendelman Shoshana | director, officer: President and CEO | 2024-08-12 | S-Sale | 5.98 | 2024-08-14 |
| Shendelman Shoshana | director, officer: President and CEO | 2024-08-13 | S-Sale | 6.18 | 2024-08-14 |
| Shendelman Shoshana | director, officer: President and CEO | 2024-08-14 | S-Sale | 5.93 | 2024-08-14 |
| Shendelman Shoshana | director, officer: President and CEO | 2024-08-05 | G-Gift | 0 | 2024-08-14 |
| Shendelman Shoshana | director, officer: President and CEO | 2024-08-05 | G-Gift | 0 | 2024-08-14 |
| Shendelman Shoshana | director, 10 percent owner, officer: President and CEO | 2024-06-06 | S-Sale | 4.32 | 2024-06-10 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2024-06-06 | S-Sale | 4.32 | 2024-06-10 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2024-06-06 | S-Sale | 4.32 | 2024-06-10 |
| Kanter Stacy J. | director | 2024-06-06 | A-Award | 0 | 2024-06-07 |
| SKYLER JAY S | director | 2024-06-06 | A-Award | 0 | 2024-06-07 |
| MARCUS JOEL S | director | 2024-06-06 | A-Award | 0 | 2024-06-07 |
| Lerner Teena | director | 2024-06-06 | A-Award | 0 | 2024-06-07 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2024-06-04 | S-Sale | 4.21 | 2024-06-06 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2024-06-05 | S-Sale | 4.24 | 2024-06-06 |
| Hooks Corwin Dale | officer: Chief Commercial Officer | 2024-04-12 | A-Award | 0 | 2024-04-15 |
| Hooks Corwin Dale | 2024-04-12 | 0 | 2024-04-15 | ||
| Shendelman Shoshana | director, 10 percent owner, officer: President and CEO | 2024-03-14 | S-Sale | 5.39 | 2024-03-18 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2024-03-14 | S-Sale | 5.39 | 2024-03-18 |
| Hansard Adam | officer: Chief Commercial Officer | 2024-03-14 | S-Sale | 5.39 | 2024-03-18 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2024-03-14 | S-Sale | 5.39 | 2024-03-18 |
| Chinoporos Constantine | officer: See Remarks | 2023-12-28 | A-Award | 0 | 2024-03-18 |
| Chinoporos Constantine | officer | 2023-12-28 | 0 | 2024-03-18 | |
| Shendelman Shoshana | director, 10 percent owner, officer: President and CEO | 2023-12-21 | A-Award | 0 | 2023-12-22 |
| Shendelman Shoshana | director, 10 percent owner, officer: President and CEO | 2023-12-21 | A-Award | 0 | 2023-12-22 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2023-12-21 | A-Award | 0 | 2023-12-22 |
| Hansard Adam | officer: Chief Commercial Officer | 2023-12-21 | A-Award | 0 | 2023-12-22 |
| Kanter Stacy J. | director | 2023-12-01 | P-Purchase | 2.1789 | 2023-12-05 |
| Shendelman Shoshana | director, 10 percent owner, officer: President and CEO | 2023-11-30 | S-Sale | 1.97 | 2023-12-01 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2023-11-30 | S-Sale | 1.97 | 2023-12-01 |
| Hansard Adam | officer: Chief Commercial Officer | 2023-11-30 | S-Sale | 1.97 | 2023-12-01 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-11-29 | J-Other | 0 | 2023-12-01 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-11-29 | J-Other | 0 | 2023-12-01 |
| Funtleyder Leslie D. | director, officer: Chief Financial Officer | 2023-11-20 | A-Award | 0 | 2023-11-20 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-11-02 | S-Sale | 2.32 | 2023-11-06 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-11-03 | S-Sale | 2.31 | 2023-11-06 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-10-31 | S-Sale | 2.41 | 2023-11-02 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-11-01 | S-Sale | 2.36 | 2023-11-02 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-10-12 | J-Other | 0 | 2023-10-16 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-10-12 | J-Other | 0.0001 | 2023-10-16 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-10-12 | J-Other | 0 | 2023-10-16 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10 percent owner | 2023-10-12 | J-Other | 0.0001 | 2023-10-16 |
| Shendelman Shoshana | director, 10 percent owner, officer: President and CEO | 2023-09-27 | S-Sale | 2.7 | 2023-09-29 |
| Perfetti Riccardo | officer: Chief Medical Officer | 2023-09-27 | S-Sale | 2.7 | 2023-09-29 |
| Hansard Adam | officer: Chief Commercial Officer | 2023-09-27 | S-Sale | 2.7 | 2023-09-29 |